These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 25940437)

  • 1. From the core to beyond the margin: a genomic picture of glioblastoma intratumor heterogeneity.
    Aubry M; de Tayrac M; Etcheverry A; Clavreul A; Saikali S; Menei P; Mosser J
    Oncotarget; 2015 May; 6(14):12094-109. PubMed ID: 25940437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics.
    Sottoriva A; Spiteri I; Piccirillo SG; Touloumis A; Collins VP; Marioni JC; Curtis C; Watts C; Tavaré S
    Proc Natl Acad Sci U S A; 2013 Mar; 110(10):4009-14. PubMed ID: 23412337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.
    Maher EA; Brennan C; Wen PY; Durso L; Ligon KL; Richardson A; Khatry D; Feng B; Sinha R; Louis DN; Quackenbush J; Black PM; Chin L; DePinho RA
    Cancer Res; 2006 Dec; 66(23):11502-13. PubMed ID: 17114236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated genomic analysis of survival outliers in glioblastoma.
    Peng S; Dhruv H; Armstrong B; Salhia B; Legendre C; Kiefer J; Parks J; Virk S; Sloan AE; Ostrom QT; Barnholtz-Sloan JS; Tran NL; Berens ME
    Neuro Oncol; 2017 Jun; 19(6):833-844. PubMed ID: 27932423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined analysis of genome-wide expression and copy number profiles to identify key altered genomic regions in cancer.
    Fontanillo C; Aibar S; Sanchez-Santos JM; De Las Rivas J
    BMC Genomics; 2012; 13 Suppl 5(Suppl 5):S5. PubMed ID: 23095915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative genome-wide analysis reveals a robust genomic glioblastoma signature associated with copy number driving changes in gene expression.
    de Tayrac M; Etcheverry A; Aubry M; Saïkali S; Hamlat A; Quillien V; Le Treut A; Galibert MD; Mosser J
    Genes Chromosomes Cancer; 2009 Jan; 48(1):55-68. PubMed ID: 18828157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups.
    Hinrichs BH; Newman S; Appin CL; Dunn W; Cooper L; Pauly R; Kowalski J; Rossi MR; Brat DJ
    Acta Neuropathol Commun; 2016 Jan; 4():4. PubMed ID: 26757882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing the peritumoral brain zone in glioblastoma: a multidisciplinary analysis.
    Lemée JM; Clavreul A; Aubry M; Com E; de Tayrac M; Eliat PA; Henry C; Rousseau A; Mosser J; Menei P
    J Neurooncol; 2015 Mar; 122(1):53-61. PubMed ID: 25559687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network analysis of genomic alteration profiles reveals co-altered functional modules and driver genes for glioblastoma.
    Gu Y; Wang H; Qin Y; Zhang Y; Zhao W; Qi L; Zhang Y; Wang C; Guo Z
    Mol Biosyst; 2013 Mar; 9(3):467-77. PubMed ID: 23344900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray-based comparative genomic hybridization (array-CGH) as a useful tool for identifying genes involved in Glioblastoma (GB).
    Ruano Y; Mollejo M; de Lope AR; Hernández-Moneo JL; Martínez P; Meléndez B
    Methods Mol Biol; 2010; 653():35-45. PubMed ID: 20721736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling.
    Ruano Y; Mollejo M; Ribalta T; Fiaño C; Camacho FI; Gómez E; de Lope AR; Hernández-Moneo JL; Martínez P; Meléndez B
    Mol Cancer; 2006 Sep; 5():39. PubMed ID: 17002787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatiotemporal genomic architecture informs precision oncology in glioblastoma.
    Lee JK; Wang J; Sa JK; Ladewig E; Lee HO; Lee IH; Kang HJ; Rosenbloom DS; Camara PG; Liu Z; van Nieuwenhuizen P; Jung SW; Choi SW; Kim J; Chen A; Kim KT; Shin S; Seo YJ; Oh JM; Shin YJ; Park CK; Kong DS; Seol HJ; Blumberg A; Lee JI; Iavarone A; Park WY; Rabadan R; Nam DH
    Nat Genet; 2017 Apr; 49(4):594-599. PubMed ID: 28263318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone.
    Lemée JM; Clavreul A; Menei P
    Neuro Oncol; 2015 Oct; 17(10):1322-32. PubMed ID: 26203067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic landscapes by multiregion sequencing combined with circulation tumor DNA detection contribute to molecular diagnosis in glioblastomas.
    Yang C; Tan Y; Li S; Zhou J; Wang Q; Wang Y; Xie Y; Chen L; Li J; Fang C; Kang C
    Aging (Albany NY); 2019 Dec; 11(23):11224-11243. PubMed ID: 31822636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and cellular heterogeneity: the hallmark of glioblastoma.
    Aum DJ; Kim DH; Beaumont TL; Leuthardt EC; Dunn GP; Kim AH
    Neurosurg Focus; 2014 Dec; 37(6):E11. PubMed ID: 25434380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effect of different levels of genomic data for cancer clinical outcome prediction.
    Kim D; Shin H; Song YS; Kim JH
    J Biomed Inform; 2012 Dec; 45(6):1191-8. PubMed ID: 22910106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning approaches to study glioblastoma: A review of the last decade of applications.
    Valdebenito J; Medina F
    Cancer Rep (Hoboken); 2019 Dec; 2(6):e1226. PubMed ID: 32729254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional genomic analysis of glioblastoma multiforme through short interfering RNA screening: a paradigm for therapeutic development.
    Thaker NG; Zhang F; McDonald PR; Shun TY; Lazo JS; Pollack IF
    Neurosurg Focus; 2010 Jan; 28(1):E4. PubMed ID: 20043719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candidate glioblastoma development gene identification using concordance between copy number abnormalities and gene expression level changes.
    Lo KC; Rossi MR; LaDuca J; Hicks DG; Turpaz Y; Hawthorn L; Cowell JK
    Genes Chromosomes Cancer; 2007 Oct; 46(10):875-94. PubMed ID: 17620294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of microarray and sage techniques in gene expression analysis of human glioblastoma.
    Kavsan VM; Dmitrenko VV; Shostak KO; Bukreieva TV; Vitak NY; Simirenko OE; Malisheva TA; Shamayev MI; Rozumenko VD; Zozulya YA
    Tsitol Genet; 2007; 41(1):36-55. PubMed ID: 17427416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.